Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 1321 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Biomerica provides update on inFoods® IBS expansion

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Biomerica, Inc.

Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Celularity Inc.

Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Neurona Therapeutics Inc.

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Viracta Therapeutics, Inc.

Extendicare Announces April 2024 Dividend of C$0.04 per Share

Read more ››
By: GlobeNewswire - 15 Apr 2024

Chiesi USA Appoints Richard Smith as Vice President and Business Unit Leader, U.S. AIR

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Chiesi USA, Inc.

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Amarin Corporation plc

REPEAT – MEDIA ADVISORY: Press conferences with patients who have been charged user fees of hundreds or even thousands of dollars at for-profit surgery clinics

Read more ››
By: GlobeNewswire - 15 Apr 2024

Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Akari Therapeutics Plc

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Daxor Corporation

Spinogenix Announces U.S. FDA Approval of its Investigational New Drug Application for its Phase 2a Clinical Trial of SPG601 for Fragile X Syndrome

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Spinogenix Inc

Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Corcept Therapeutics Incorporated

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Read more ››
By: GlobeNewswire - 15 Apr 2024

Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Pulmocide Ltd

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Reviva Pharmaceuticals, Inc.

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Organovo Holdings, Inc.

PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

Read more ››
By: GlobeNewswire - 15 Apr 2024

IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  IO Biotech, Inc.

The United States FDA Awards Orphan Drug Designation (ODD) to NM5072 for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)

Read more ››
By: GlobeNewswire - 15 Apr 2024

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Reviva Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑